138 related articles for article (PubMed ID: 15650785)
41. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
[TBL] [Abstract][Full Text] [Related]
42. Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.
Quadeer AA; Louie RH; Shekhar K; Chakraborty AK; Hsing IM; McKay MR
J Virol; 2014 Jul; 88(13):7628-44. PubMed ID: 24760894
[TBL] [Abstract][Full Text] [Related]
43. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
44. [Detection of antibodies to the nucleocapsid protein of Hepatitis C virus by immunoenzyme analysis using synthetic peptides of nucleocapsid N-terminal part].
Firsova TV; Alekseenkova TI; Shibnev VA; Froesner G; Semiletov IuA
Vopr Virusol; 2001; 46(2):21-4. PubMed ID: 11392965
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination.
Gupte GM; Arankalle VA
Virol J; 2012 Mar; 9():74. PubMed ID: 22452828
[TBL] [Abstract][Full Text] [Related]
46. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
[TBL] [Abstract][Full Text] [Related]
47. Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.
Chuang WC; Allain JP
J Gen Virol; 2008 Aug; 89(Pt 8):1890-1900. PubMed ID: 18632960
[TBL] [Abstract][Full Text] [Related]
48. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus.
Eckels DD; Zhou H; Bian TH; Wang H
Int Immunol; 1999 Apr; 11(4):577-83. PubMed ID: 10323211
[TBL] [Abstract][Full Text] [Related]
49. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
50. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
[TBL] [Abstract][Full Text] [Related]
51. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.
Pereboeva LA; Pereboev AV; Morris GE
J Med Virol; 1998 Oct; 56(2):105-11. PubMed ID: 9746064
[TBL] [Abstract][Full Text] [Related]
52. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
Cusick MF; Yang M; Gill JC; Eckels DD
Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
[TBL] [Abstract][Full Text] [Related]
53. Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.
Bagaglio S; Bruno R; Lodrini S; De Mitri MS; Andreone P; Loggi E; Galli L; Lazzarin A; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):153-61. PubMed ID: 14518715
[TBL] [Abstract][Full Text] [Related]
54. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
[TBL] [Abstract][Full Text] [Related]
55. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
[TBL] [Abstract][Full Text] [Related]
56. Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.
Tsukiyama-Kohara K; Yamaguchi K; Maki N; Ohta Y; Miki K; Mizokami M; Ohba K; Tanaka S; Hattori N; Nomoto A
Virology; 1993 Feb; 192(2):430-7. PubMed ID: 7678473
[TBL] [Abstract][Full Text] [Related]
57. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.
Pereboeva LA; Pereboev AV; Wang LF; Morris GE
J Med Virol; 2000 Feb; 60(2):144-51. PubMed ID: 10596013
[TBL] [Abstract][Full Text] [Related]
59. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
60. Antigenic structure of the hepatitis C virus envelope 2 protein.
Zhang ZX; Sönnerborg A; Sällberg M
Clin Exp Immunol; 1994 Dec; 98(3):382-7. PubMed ID: 7527739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
